Humacyte, Inc. (HUMA)
NASDAQ: HUMA · IEX Real-Time Price · USD
4.71
0.02 (0.43%)
At close: May 20, 2022 4:00 PM
4.91
0.20 (4.25%)
After-hours:May 20, 2022 5:13 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 1.26 | 1.49 | 6.19 |
| Revenue Growth (YoY) | -15.29% | -75.90% | - |
| Gross Profit | 1.26 | 1.49 | 6.19 |
| Selling, General & Admin | 21.13 | 12.01 | 16.28 |
| Research & Development | 61.34 | 54.08 | 75.6 |
| Operating Expenses | 82.47 | 66.09 | 91.88 |
| Operating Income | -81.21 | -64.6 | -85.69 |
| Interest Expense / Income | 4.35 | 2.2 | 2.3 |
| Other Expense / Income | -59.08 | -0.28 | -2.57 |
| Pretax Income | -26.48 | -66.52 | -85.42 |
| Net Income | -26.48 | -66.52 | -85.42 |
| Net Income Common | -26.48 | -66.52 | -85.42 |
| Shares Outstanding (Basic) | 40 | 6 | 20 |
| Shares Outstanding (Diluted) | 40 | 6 | 20 |
| Shares Change | 593.25% | -71.34% | - |
| EPS (Basic) | -0.66 | -11.54 | -4.25 |
| EPS (Diluted) | -0.66 | -11.54 | -4.25 |
| Free Cash Flow Per Share | -2.04 | -9.68 | -3.97 |
| Gross Margin | 100.00% | 100.00% | 100.00% |
| Operating Margin | -6429.77% | -4332.66% | -1385.02% |
| Profit Margin | -2096.36% | -4461.70% | -1380.67% |
| Free Cash Flow Margin | -6445.76% | -3744.87% | -1291.61% |
| EBITDA | -13.85 | -55.89 | -76.31 |
| EBITDA Margin | -1096.28% | -3748.49% | -1233.44% |
| EBIT | -22.13 | -64.32 | -83.12 |
| EBIT Margin | -1752.10% | -4314.02% | -1343.53% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).